Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia
2009
Improving Chronic Myeloid Leukemia Treatment with Drug Combinations
publication
Evidence: moderate
Author Information
Author(s): Komarova Natalia L., Katouli Allen A., Wodarz Dominik
Primary Institution: University of California Irvine
Hypothesis
Can combining two targeted drugs improve treatment outcomes for chronic myeloid leukemia despite drug resistance?
Conclusion
Combining two effective drugs improves treatment success for chronic myeloid leukemia, but adding a third drug does not provide additional benefits.
Supporting Evidence
- Combining two drugs increases the probability of treatment success despite drug resistance.
- Using three drugs does not improve treatment outcomes compared to using two.
- The model suggests that the number of mutations conferring resistance affects treatment success.
Takeaway
Using two specific cancer drugs together can help patients more than using just one, but using three drugs doesn't help any more than two.
Methodology
Mathematical modeling of cancer cell dynamics and drug resistance.
Limitations
The model's predictions depend on the number of tumor cells and may not apply to all patient scenarios.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website